Simul Parikh, Medical Director at Lake Huron Medical Center, and Medical Director of OncoHealth, shared on LinkedIn:
“I’ve felt a little stagnant clinically the last few years. I stay up to date, discuss cases, go to meetings – but my actual practice hasn’t changed all that much.
So I decided to learn something new:
Focal microboosting for prostate cancer.
The more I dug into FLAME, ASCENDE-RT, the imaging, planning, and practical implementation, the more convinced I became that we should be doing this far more often.
The long-term biochemical benefit from dose escalation is substantial.
Brachytherapy remains an excellent option, but when it isn’t available, isn’t appropriate, or a patient declines it, simply stopping at the standard whole-gland dose deserves another look.
I wrote about the evidence, the objections I had myself, and what I’ve learned actually trying to implement microboost in practice.
Including the parts that took me longer than they probably should have.
Would love to hear how others are approaching this.
Read further here.”
Other articles about Prostate Cancer on OncoDaily.